Swifty biotech enters into a licensing agreement with pang


Question - Swifty Biotech enters into a licensing agreement with Pang Pharmaceutical for a drug under development. Swifty will receive a payment of $10,300,000 if the drug receives regulatory approval. Based on prior experience in the drug-approval process, Swifty determines it is 90% likely that the drug will gain approval and a 10% chance of denial.

Determine the transaction price of the arrangement for Swifty Biotech.

Solution Preview :

Prepared by a verified Expert
Accounting Basics: Swifty biotech enters into a licensing agreement with pang
Reference No:- TGS02496514

Now Priced at $25 (50% Discount)

Recommended (92%)

Rated (4.4/5)